Literature DB >> 33178552

Candida auris infection and biofilm formation: going beyond the surface.

Mark V Horton1, Jeniel E Nett1.   

Abstract

PURPOSE OF REVIEW: Emergent fungal pathogen C. auris is spreading in hospitals throughout the world and mortality rates for patients with invasive disease approach 60%. This species exhibits a heightened capacity to colonize skin, persist on hospital surfaces, rapidly disseminate in healthcare settings, and resist antifungal therapy. RECENT
FINDINGS: Current investigations show that C. auris produces biofilms, surface-adherent communities that resist antifungals and withstand desiccation. These biofilms form when C. auris is growing on skin or in conditions expected in the hospital environment and on implanted medical devices.
SUMMARY: Here we will highlight the topic of biofilm formation by C. auris. We illustrate how this process influences resistance to antimicrobials and promotes nosocomial transmission.

Entities:  

Keywords:  Candida auris; antifungal resistance; biofilm; colonization; pathogenicity; skin

Year:  2020        PMID: 33178552      PMCID: PMC7654955          DOI: 10.1007/s40588-020-00143-7

Source DB:  PubMed          Journal:  Curr Clin Microbiol Rep        ISSN: 2196-5471


  47 in total

1.  Neurosurgical device-associated infections due to Candida auris - Three cases from a single tertiary center.

Authors:  Elham Khatamzas; Hilary Madder; Katie Jeffery
Journal:  J Infect       Date:  2019-02-10       Impact factor: 6.072

2.  Farnesol increases the activity of echinocandins against Candida auris biofilms.

Authors:  Fruzsina Nagy; Zoltán Tóth; Lajos Daróczi; Adrien Székely; Andrew M Borman; László Majoros; Renátó Kovács
Journal:  Med Mycol       Date:  2020-04-01       Impact factor: 4.076

3.  Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses.

Authors:  Shawn R Lockhart; Kizee A Etienne; Snigdha Vallabhaneni; Joveria Farooqi; Anuradha Chowdhary; Nelesh P Govender; Arnaldo Lopes Colombo; Belinda Calvo; Christina A Cuomo; Christopher A Desjardins; Elizabeth L Berkow; Mariana Castanheira; Rindidzani E Magobo; Kauser Jabeen; Rana J Asghar; Jacques F Meis; Brendan Jackson; Tom Chiller; Anastasia P Litvintseva
Journal:  Clin Infect Dis       Date:  2016-10-20       Impact factor: 9.079

4.  Candida auris candidaemia in Indian ICUs: analysis of risk factors.

Authors:  Shivaprakash M Rudramurthy; Arunaloke Chakrabarti; Raees A Paul; Prashant Sood; Harsimran Kaur; Malini R Capoor; Anupma J Kindo; Rungmei S K Marak; Anita Arora; Raman Sardana; Shukla Das; Deepinder Chhina; Atul Patel; Immaculata Xess; Bansidhar Tarai; Pankaj Singh; Anup Ghosh
Journal:  J Antimicrob Chemother       Date:  2017-06-01       Impact factor: 5.790

5.  Candida auris for the clinical microbiology laboratory: Not your grandfather's Candida species.

Authors:  Shawn R Lockhart; Elizabeth L Berkow; Nancy Chow; Rory M Welsh
Journal:  Clin Microbiol Newsl       Date:  2017-07-01

6.  Candida auris: a comparison between planktonic and biofilm susceptibility to antifungal drugs.

Authors:  David Romera; John Jairo Aguilera-Correa; Ignacio Gadea; Lourdes Viñuela-Sandoval; Julio García-Rodríguez; Jaime Esteban
Journal:  J Med Microbiol       Date:  2019-07-04       Impact factor: 2.472

7.  Role of Fks1p and matrix glucan in Candida albicans biofilm resistance to an echinocandin, pyrimidine, and polyene.

Authors:  Jeniel E Nett; Kyler Crawford; Karen Marchillo; David R Andes
Journal:  Antimicrob Agents Chemother       Date:  2010-06-01       Impact factor: 5.191

8.  Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997-2016.

Authors:  Michael A Pfaller; Daniel J Diekema; John D Turnidge; Mariana Castanheira; Ronald N Jones
Journal:  Open Forum Infect Dis       Date:  2019-03-15       Impact factor: 3.835

9.  Candida auris in Healthcare Facilities, New York, USA, 2013-2017.

Authors:  Eleanor Adams; Monica Quinn; Sharon Tsay; Eugenie Poirot; Sudha Chaturvedi; Karen Southwick; Jane Greenko; Rafael Fernandez; Alex Kallen; Snigdha Vallabhaneni; Valerie Haley; Brad Hutton; Debra Blog; Emily Lutterloh; Howard Zucker
Journal:  Emerg Infect Dis       Date:  2018-10       Impact factor: 6.883

10.  Candida auris Forms High-Burden Biofilms in Skin Niche Conditions and on Porcine Skin.

Authors:  Mark V Horton; Chad J Johnson; John F Kernien; Tarika D Patel; Brandon C Lam; J Z Alex Cheong; Jennifer J Meudt; Dhanansayan Shanmuganayagam; Lindsay R Kalan; Jeniel E Nett
Journal:  mSphere       Date:  2020-01-22       Impact factor: 4.389

View more
  12 in total

1.  In vitro and in vivo photodynamic efficacies of novel and conventional phenothiazinium photosensitizers against multidrug-resistant Candida auris.

Authors:  Patrícia Helena Grizante Barião; Ludmilla Tonani; Guilherme Thomaz Pereira Brancini; Erika Nascimento; Gilberto Úbida Leite Braga; Mark Wainwright; Marcia Regina von Zeska Kress
Journal:  Photochem Photobiol Sci       Date:  2022-07-11       Impact factor: 4.328

Review 2.  Candida auris, a singular emergent pathogenic yeast: its resistance and new therapeutic alternatives.

Authors:  Liliana Fernandes; Rita Ribeiro; Mariana Henriques; Maria Elisa Rodrigues
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-10-06       Impact factor: 5.103

3.  In vitro and in vivo interaction of caspofungin with isavuconazole against Candida auris planktonic cells and biofilms.

Authors:  Fruzsina Nagy; Zoltán Tóth; Fanni Nyikos; Lajos Forgács; Ágnes Jakab; Andrew M Borman; László Majoros; Renátó Kovács
Journal:  Med Mycol       Date:  2021-10-04       Impact factor: 4.076

Review 4.  Candida auris: A Quick Review on Identification, Current Treatments, and Challenges.

Authors:  Lucia Černáková; Maryam Roudbary; Susana Brás; Silva Tafaj; Célia F Rodrigues
Journal:  Int J Mol Sci       Date:  2021-04-25       Impact factor: 5.923

5.  Shining light on multi-drug resistant Candida auris: Ultraviolet-C disinfection, wavelength sensitivity, and prevention of biofilm formation of an emerging yeast pathogen.

Authors:  Richard M Mariita; James H Davis; Michelle M Lottridge; Rajul V Randive
Journal:  Microbiologyopen       Date:  2022-02       Impact factor: 3.139

6.  DOCK2 regulates antifungal immunity by regulating RAC GTPase activity.

Authors:  Xiaojian Ma; Xi Tan; Bingbing Yu; Wanwei Sun; Heping Wang; Huijun Hu; Yanyun Du; Ruirui He; Ru Gao; Qianwen Peng; Zhihui Cui; Ting Pan; Xiong Feng; Junhan Wang; Chengqi Xu; Bin Zhu; Wei Liu; Chenhui Wang
Journal:  Cell Mol Immunol       Date:  2022-01-25       Impact factor: 22.096

7.  Photodynamic Therapy Is Effective Against Candida auris Biofilms.

Authors:  Priyanka S Bapat; Clarissa J Nobile
Journal:  Front Cell Infect Microbiol       Date:  2021-09-03       Impact factor: 5.293

Review 8.  Antifungal lock therapy: an eternal promise or an effective alternative therapeutic approach?

Authors:  R Kovács; L Majoros
Journal:  Lett Appl Microbiol       Date:  2022-01-30       Impact factor: 2.813

9.  Silver Nanoparticles: A Promising Antifungal Agent against the Growth and Biofilm Formation of the Emergent Candida auris.

Authors:  Reem AlJindan; Doaa M AlEraky
Journal:  J Fungi (Basel)       Date:  2022-07-19

10.  Nanostructured Lipid Carriers Loaded with Lippia sidoides Essential Oil as a Strategy to Combat the Multidrug-Resistant Candida auris.

Authors:  Iara Baldim; Mario H Paziani; Patrícia H Grizante Barião; Marcia R von Zeska Kress; Wanderley P Oliveira
Journal:  Pharmaceutics       Date:  2022-01-13       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.